Page last updated: 2024-08-21

hesperidin and plerixafor

hesperidin has been researched along with plerixafor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, Y; Lu, H; Sheng, X; Xia, R; Xu, G; Xu, X	1

Other Studies

1 other study(ies) available for hesperidin and plerixafor

Article	Year
Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway. Life sciences, 2018, May-15, Volume: 201 Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Benzylamines; Carcinoma, Non-Small-Cell Lung; Cell Movement; Chemokine CXCL12; Chemotaxis; Cyclams; Dose-Response Relationship, Drug; Hesperidin; Heterocyclic Compounds; Humans; Lung Neoplasms; Neoplasm Invasiveness; Neoplasm Proteins; Receptors, CXCR4; Signal Transduction; Wound Healing	2018

Article

Year

Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway.

Life sciences, 2018, May-15, Volume: 201

Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Benzylamines; Carcinoma, Non-Small-Cell Lung; Cell Movement; Chemokine CXCL12; Chemotaxis; Cyclams; Dose-Response Relationship, Drug; Hesperidin; Heterocyclic Compounds; Humans; Lung Neoplasms; Neoplasm Invasiveness; Neoplasm Proteins; Receptors, CXCR4; Signal Transduction; Wound Healing

2018